The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) of oxaliplatin plus fluorouracil/leucovorin compared with HAIC of
oxaliplatin alone in patients with hepatocellular carcinoma (HCC) with major portal venous
tumor thrombus (PVTT).
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Dongguan People's Hospital First Affiliated Hospital Xi'an Jiaotong University First Affiliated Hospital, Sun Yat-Sen University Guangzhou No.12 People's Hospital Guangzhou Twelfth People 's Hospital Kaiping Central Hospital The First Affiliated Hospital of University of South China